Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
SSE:600329
Price:
31.44
CNY
0.48%
Market Closed
Market Cap:
24.2B
CNY
Balance Sheet
Balance Sheet Decomposition
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
| Current Assets | 7.1B |
| Cash & Short-Term Investments | 1.5B |
| Receivables | 2.9B |
| Other Current Assets | 2.8B |
| Non-Current Assets | 3.8B |
| Long-Term Investments | 942.1m |
| PP&E | 1.5B |
| Intangibles | 371m |
| Other Non-Current Assets | 1.1B |
Balance Sheet
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd
Currency: CNY
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
631
|
1 108
|
1 164
|
975
|
1 455
|
1 479
|
1 987
|
2 283
|
2 712
|
1 997
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2 283
|
2 712
|
1 997
|
|
| Cash Equivalents |
631
|
1 108
|
1 164
|
975
|
1 455
|
1 479
|
1 987
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
2
|
1
|
0
|
53
|
44
|
0
|
484
|
41
|
20
|
|
| Total Receivables |
1 740
|
1 739
|
1 496
|
1 541
|
1 729
|
1 809
|
2 007
|
2 084
|
2 821
|
2 723
|
|
| Accounts Receivables |
1 326
|
1 279
|
1 194
|
1 249
|
1 320
|
1 373
|
1 513
|
1 537
|
2 146
|
2 173
|
|
| Other Receivables |
414
|
460
|
302
|
292
|
409
|
436
|
495
|
547
|
675
|
550
|
|
| Inventory |
860
|
974
|
929
|
1 105
|
1 328
|
1 595
|
1 488
|
1 525
|
1 429
|
1 567
|
|
| Other Current Assets |
151
|
176
|
364
|
340
|
215
|
209
|
121
|
49
|
243
|
245
|
|
| Total Current Assets |
3 382
|
3 999
|
3 954
|
3 961
|
4 780
|
5 135
|
5 604
|
6 425
|
7 245
|
6 552
|
|
| PP&E Net |
871
|
924
|
1 004
|
1 088
|
1 216
|
1 413
|
1 478
|
1 521
|
1 504
|
1 492
|
|
| PP&E Gross |
871
|
924
|
1 004
|
1 088
|
1 216
|
1 413
|
1 478
|
1 521
|
1 504
|
1 492
|
|
| Accumulated Depreciation |
927
|
972
|
1 005
|
1 031
|
1 066
|
1 130
|
1 205
|
1 258
|
1 356
|
1 461
|
|
| Intangible Assets |
193
|
188
|
181
|
179
|
175
|
176
|
204
|
203
|
292
|
331
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
85
|
66
|
|
| Long-Term Investments |
888
|
863
|
1 203
|
1 279
|
797
|
930
|
825
|
756
|
816
|
1 518
|
|
| Other Long-Term Assets |
103
|
96
|
103
|
115
|
142
|
191
|
173
|
162
|
215
|
271
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
85
|
66
|
|
| Total Assets |
5 437
N/A
|
6 069
+12%
|
6 444
+6%
|
6 622
+3%
|
7 110
+7%
|
7 843
+10%
|
8 283
+6%
|
9 067
+9%
|
10 157
+12%
|
10 230
+1%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
659
|
645
|
546
|
538
|
588
|
661
|
666
|
599
|
724
|
615
|
|
| Accrued Liabilities |
106
|
122
|
121
|
125
|
165
|
191
|
161
|
163
|
305
|
337
|
|
| Short-Term Debt |
1 042
|
606
|
873
|
380
|
264
|
6
|
236
|
735
|
913
|
707
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
32
|
4
|
4
|
|
| Other Current Liabilities |
554
|
467
|
428
|
818
|
897
|
1 298
|
1 100
|
906
|
1 387
|
1 571
|
|
| Total Current Liabilities |
2 362
|
1 840
|
1 969
|
1 862
|
1 915
|
2 157
|
2 164
|
2 434
|
3 333
|
3 233
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
4
|
33
|
32
|
2
|
152
|
244
|
|
| Deferred Income Tax |
9
|
9
|
7
|
7
|
6
|
9
|
4
|
4
|
9
|
7
|
|
| Minority Interest |
183
|
184
|
163
|
149
|
127
|
135
|
142
|
149
|
30
|
45
|
|
| Other Liabilities |
120
|
114
|
123
|
128
|
131
|
121
|
134
|
114
|
111
|
101
|
|
| Total Liabilities |
2 673
N/A
|
2 147
-20%
|
2 261
+5%
|
2 145
-5%
|
2 183
+2%
|
2 455
+12%
|
2 475
+1%
|
2 703
+9%
|
3 636
+35%
|
3 629
0%
|
|
| Equity | |||||||||||
| Common Stock |
739
|
769
|
769
|
769
|
769
|
773
|
774
|
773
|
773
|
770
|
|
| Retained Earnings |
1 440
|
1 781
|
1 984
|
2 344
|
2 752
|
3 209
|
3 681
|
4 218
|
4 700
|
4 828
|
|
| Additional Paid In Capital |
523
|
1 308
|
1 378
|
1 315
|
1 324
|
1 349
|
1 365
|
1 374
|
1 048
|
975
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
31
|
30
|
34
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
28
|
35
|
32
|
30
|
7
|
|
| Other Equity |
61
|
65
|
53
|
48
|
82
|
86
|
23
|
0
|
0
|
0
|
|
| Total Equity |
2 764
N/A
|
3 922
+42%
|
4 183
+7%
|
4 477
+7%
|
4 927
+10%
|
5 388
+9%
|
5 808
+8%
|
6 364
+10%
|
6 521
+2%
|
6 601
+1%
|
|
| Total Liabilities & Equity |
5 437
N/A
|
6 069
+12%
|
6 444
+6%
|
6 622
+3%
|
7 110
+7%
|
7 843
+10%
|
8 283
+6%
|
9 067
+9%
|
10 157
+12%
|
10 230
+1%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
739
|
769
|
769
|
769
|
769
|
769
|
769
|
769
|
769
|
769
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
